Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Scientific Reports|January 23, 2023
Incidence and impact of new-onset postoperative arrhythmia after surgery of the lower gastrointestinal tractFelix Rühlmann, Mara Sophie Hedicke, Deborah Engelhardt, et al.International Journal of Molecular Sciences|May 31, 2017
Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during ChemoradiotherapyPeter Jo, Azadeh Azizian, Junius Salendo, et al.Journal of Molecular and Cellular Cardiology|July 30, 2014
NADPH oxidase 2 mediates angiotensin II-dependent cellular arrhythmias via PKA and CaMKIIStefan Wagner, Christian Dantz, Hannah Flebbe, et al.International Journal of Molecular Sciences|April 20, 2016
Prognostic Value of MicroRNAs in Preoperative Treated Rectal CancerAzadeh Azizian, Ingo Epping, Frank Kramer, et al.Carcinogenesis|February 17, 2024
LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolismYuuki Ohara, Amanda J Craig, Huaitian Liu, et al.Plos One|April 12, 2016
Heterogeneity of KRAS Mutation Status in Rectal CancerPeter Jo, Alexander König, Markus Schirmer, et al.Plos One|October 1, 2020
KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancerPeter Jo, Markus Bernhardt, Manuel Nietert, et al.Biomedicines|February 24, 2024
Perioperative LiMAx Test Analysis: Impact of Portal Vein Embolisation, Chemotherapy and Major Liver ResectionFelix Rühlmann, Azadeh Azizian, Christian Moosmann, et al.International Journal of Cancer|April 17, 2024
ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancerYuuki Ohara, Huaitian Liu, Amanda J Craig, et al.Carcinogenesis|August 13, 2024
ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancerPaloma Moreno, Yuuki Ohara, Amanda J Craig, et al.Pageof 3